Stanningly Pharma Ltd,
BioCity, Pennyfoot Street,
Telephone: +44 (0) 1159 124253
Web site: www.stanningleypharma.com
What we do
Far Infrared therapy is an innovative technology for fistula management which has been widely adopted in the country of origin. The introduction of a product that will improve fistula outcomes, in an environment of healthcare reforms and efficiency savings, defines the very ethos of Stanningley Pharma. Furthermore, the company is generously supporting renal departments with trial opportunities, and is planning two other product launches this year. Stanningley Pharma is a new company built on the foundations of people with longstanding experience and expertise in nephrology. The company’s achievements to date, demonstrate its commitment to innovation, serving both the needs of renal patients and healthcare professionals.